HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
ParticipantGs
Global strategic investor
Activity from announced rounds
Activity in this selectionopenai-0702931a
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $91.7M 1 disclosed · full round size, not this investor’s share